secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001641489-23-000088
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics loses Huadong license for TTP273; director Harjivan resigns
----------------------------------------------------------------------------

- Huadong terminates TTP273 license for China/Pacific Rim; Huadong discontinues development.
- Termination effective after negotiation of final agreement; process ongoing.
- Director Chandresh Harjivan resigns from board, no disagreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000088/0001641489-23-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000088/vtvt-20231218.htm
  HTML page:      https://secwatch.observer/filing/0001641489-23-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer